ESCRS 2023: Integrated workflow solutions in cataract procedures

News
Video

Euan Thomson, the President of Ophthalmic Devices, Carl Zeiss Meditec spoke with our team about integrated workflow solutions and how they can benefit cataract procedures while at the 2023 ESCRS meeting in Vienna, Austria.

Euan Thomson, the President of Ophthalmic Devices, Carl Zeiss Meditec spoke with our team about integrated workflow solutions and how they can benefit cataract procedures while at the 2023 ESCRS meeting in Vienna, Austria.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Euan Thomson: So I'm Euan Thompson, I'm President of Ophthalmology at Carl Zeiss, and Head of Digital Business. You know, we're working very hard on creating integrated workflow solutions. This is a big theme for us. And I think that, as people go around our booth, there's actually going to be a high level of integration that we've already been able to achieve.

Some of our workflows are complete; cataract workflow, for example, is there. And we've actually been able to demonstrate the value of this to customers. So we're really targeting new value propositions beyond the technology itself. We're really looking at efficiency gains in the operating room efficiency gains in the run up to a treatment. We're looking at quality improvement, standardization, and we're actually already gathering data on these. So we're really excited about that and really looking forward to showcasing it today.

So what I'm looking forward to in 2024, is really, really demonstrating the power of the level of integration that we've achieved, you know, our digitally connected workflows are really quite evolved now. The true value of those in terms of, you know, the efficiency gains and standardization and so on these new value propositions, being able to test those and getting the data back is really exciting, you know. A cataract workflow, we've actually now got demonstrable data that shows that there is a true efficiency gain, not just in the run up to a treatment but in the operating room itself. And it can be as high as 30% timesaving in the operating room for some procedures. So this is meaningful improvements in the standard of care.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.